233 related articles for article (PubMed ID: 18752151)
21. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
[TBL] [Abstract][Full Text] [Related]
22. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
Nanda A; Chen MH; Renshaw AA; D'Amico AV
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1419-23. PubMed ID: 19131185
[TBL] [Abstract][Full Text] [Related]
23. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.
Bastide C; Brenot-Rossi I; Garcia S; Rossi D
Eur J Surg Oncol; 2009 Jul; 35(7):751-6. PubMed ID: 18538526
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT.
Borley N; Fabrin K; Sriprasad S; Mondaini N; Thompson P; Muir G; Poulsen J
Scand J Urol Nephrol; 2003; 37(5):382-6. PubMed ID: 14594685
[TBL] [Abstract][Full Text] [Related]
25. [Laparoscopic lymphadenectomy. Current indications].
Rioja Sanz C; Blas Marín M; Rioja Sanz L
Arch Esp Urol; 2002; 55(6):667-78. PubMed ID: 12224165
[TBL] [Abstract][Full Text] [Related]
26. Risk of nodal metastases at laparoscopic pelvic lymphadenectomy using PSA, Gleason score, and clinical stage in men with localized prostate cancer.
Hoenig DM; Chi S; Porter C; Tackett L; Smith DS; Cohen SI; Stein BS
J Endourol; 1997 Aug; 11(4):263-5. PubMed ID: 9376845
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of high risk prostate cancer: the Mayo Clinic experience.
Boorjian SA; Blute ML
Urol Oncol; 2008; 26(5):530-2. PubMed ID: 18774468
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer.
Zelefsky MJ; Yamada Y; Kollmeier MA; Shippy AM; Nedelka MA
Eur Urol; 2008 Jun; 53(6):1172-9. PubMed ID: 18222596
[TBL] [Abstract][Full Text] [Related]
29. The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
Wagner M; Sokoloff M; Daneshmand S
J Urol; 2008 Feb; 179(2):408-13. PubMed ID: 18076938
[TBL] [Abstract][Full Text] [Related]
30. Prostate Risk Index (PRIX) as a new method of risk classification for clinically localized prostate cancer.
Yoshioka Y; Inoue T
Strahlenther Onkol; 2007 Sep; 183(9):490-6. PubMed ID: 17762923
[TBL] [Abstract][Full Text] [Related]
31. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
[TBL] [Abstract][Full Text] [Related]
32. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
33. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
[TBL] [Abstract][Full Text] [Related]
34. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI
Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
[TBL] [Abstract][Full Text] [Related]
35. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
36. Overtreatment of prostate cancer may be prevented by extended pelvic lymphadenectomy.
Azawi NH; Stenfeldt K; Christensen T
Dan Med J; 2013 Sep; 60(9):A4709. PubMed ID: 24001469
[TBL] [Abstract][Full Text] [Related]
37. Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
Kava BR; Dalbagni G; Conlon KC; Russo P
Ann Surg Oncol; 1998 Mar; 5(2):173-80. PubMed ID: 9527271
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic pelvic lymphadenectomy.
Boeckmann W; Effert P; Wolff JM; Jakse G
Acta Urol Belg; 1994 Apr; 62(1):45-50. PubMed ID: 8197929
[TBL] [Abstract][Full Text] [Related]
39. Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases.
Feicke A; Baumgartner M; Talimi S; Schmid DM; Seifert HH; Müntener M; Fatzer M; Sulser T; Strebel RT
Eur Urol; 2009 Apr; 55(4):876-83. PubMed ID: 19101076
[TBL] [Abstract][Full Text] [Related]
40. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]